[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100479753":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":34,"centralContacts":39,"locations":49,"responsibleParty":65,"collaborators":68,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":81,"sex":82,"minAge":83,"maxAge":84,"enrollmentInfo":85,"targetDuration":10,"studyType":88,"phases":10,"briefSummary":89,"conditions":90,"keywords":97,"overallStatus":52,"whyStopped":10,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Helsinki University Central Hospital","OTHER",[8,12,17],{"label":9,"type":10,"description":11,"interventionNames":10},"typically developing infants",null,"recruitment at 5-8mos of age; infants are considered typically developing if they are born at term age with no neurologically significant medical history, and they are not medically followed up for a suspicion of such. The benchmark for this is taken from the nationally harmonized pre\u002Fpostnatal screening practise.",{"label":13,"type":10,"description":14,"interventionNames":15},"neurodevelopmental concern","recruitment at 5-8mos of age; infants are recruited from the outpatient clinic in the New Children's hospital (NCH). They have either a known perinatal risk factor (e.g.stroke, HIE, meningitis), or they are referred to pediatric neurologists at NCH due to a suspected delay or deviance in neurodevelopment.",[16],"Other: physiotherapy",{"label":18,"type":10,"description":19,"interventionNames":20},"hip dysplasia concern","recruitment at 2-6 weeks of age after perinatal clinical suspicion of hip dysplacia. These infants may be left out of follow-up (mild), or treated by orthopedic clinic with a soft brace (moderate) or a stronger cast (sever)",[21],"Device: brace",[23,27],{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":10},"physiotherapy","Some infants will receive physiotherapy as a part of their clinically indicated care.",[13],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"DEVICE","brace","Some infants in the hip dysplasia group will receive brace and\u002For cast as a part of their clinically indicated care",[18],[33],"cast",[35],{"name":36,"affiliation":37,"role":38},"Sampsa K Vanhatalo, prof","University of Helsinki","PRINCIPAL_INVESTIGATOR",[40,45],{"name":41,"role":42,"phone":43,"phoneExt":10,"email":44},"Sampsa Vanhatalo, prof","CONTACT","00358505286119","sampsa.vanhatalo@helsinki.fi",{"name":46,"role":42,"phone":47,"phoneExt":10,"email":48},"Leena Haataja, prof","00358504272069","leena.haataja@hus.fi",[50],{"facility":51,"status":52,"city":53,"state":10,"zip":10,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"BABA, Clinical Trial Unit, New Children's Hospital","RECRUITING","Helsinki","Finland","FI",{"type":57,"coordinates":58},"Point",[59,60],24.93545,60.16952,{"lat":60,"lon":59},[63,64],{"name":41,"role":42,"phone":10,"phoneExt":10,"email":10},{"name":46,"role":42,"phone":10,"phoneExt":10,"email":10},{"type":38,"investigatorFullName":66,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Sampsa Vanhatalo","professor in clinical neurophysiology",[69,70,72],{"name":37,"class":6},{"name":71,"class":6},"Aalto University",{"name":73,"class":6},"Tampere University","100479753","development-of-motility-and-cognition-in-infants-100479753",false,"NCT05527080","Development of Motility and Cognition in Infants","PILKE","Inclusion Criteria:\n\n* age at enrollment 5-8mos\n* typically developing\n\nExclusion Criteria:\n\n* all neurologically significant medical histories during pregnancy, at birth or postnatally\n* suspicion of developmental delay\n* suspicion or diagnosis of syndromes with neuromotor symptoms",true,"ALL","5 Months","26 Months",{"count":86,"type":87},250,"ESTIMATED","OBSERVATIONAL","PILKE study uses wearables for assessing motor development in infants in order to define functional growth trajectories in the normal infants and infants at risk of neurological compromise. In addition, PILKE studies correlation of early motor development to later neurocognitive development.",[91,92,93,94,95,96],"Neurodevelopmental Disorders","Developmental Delay","Development, Infant","Child Development","Cognitive Developmental Delay","Neurophysiologic Abnormality",[98,99,100,101,102],"wearable","medical wearable","human activity recognition","growth chart","neurodevelopment","2025-03-30",{"date":105,"type":106},"2025-04-03","ACTUAL",{"date":108,"type":106},"2021-10-01",{"date":110,"type":87},"2027-12-30",{"name":5,"class":6},1]